쎌바이오텍

049960KOSDAQ기초 의약물질 제조업

65.9 / 100

Reference Date: 2026-07-24

Financial Score30.0 / 40

News Sentiment15.9 / 25

Momentum10.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Revenue is on a declining trend. Slightly up 1.9% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Sebaitech operates in three main areas: probiotics, microbiome, and anti-cancer drug development. It maintains the top position in South Korea's probiotic exports and is developing functional foods for atopic dermatitis and menopausal symptoms through its microbiome business. The company also aims to create probiotic-based therapies for ulcerative colitis and colorectal cancer.

Number of Employees

123people

Average Salary

45.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

10.45Industry Average 25.448.0Point

Half of industry avg (excellent)

PBR

1.10Industry Average 1.264.0Point

In line with industry avg

ROE

7.92Industry Average -6.033.5Point

Well below industry avg

Debt Ratio

0.06Industry Average 6.628.0Point

Half of industry avg (excellent)

Trend 2023~20256.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼0.4% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲113.0% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 8.8% (improving, 3yr)

Detailed News Sentiment

7 totalPositive 3Neutral 4Negative 0Average Sentiment Score 63.6

Positive
쎌바이오텍 유산균 듀오락, 13년 연속 세계 수출 1위 달성
쎌바이오텍의 대표 유산균 듀오락이 13년 연속 수출 1위를 달성하며 기업의 지속적인 성장과 시장 지배력을 입증했다.
Neutral
"아기 똥 있어요?"…유산균 박사가 신생아실 간 사연[인터뷰]
인터뷰 내용은 쎌바이오텍의 연구 동향을 보여주나, 직접적인 주식 영향은 제한적입니다.
Neutral
"꼭 챙겨 떠나요"…빠니보틀 여행필수품 '유산균'
듀오락과 빠니보틀의 협업으로 여행 관련 유산균 제품 출시 소식이지만, 쎌바이오텍의 직접적인 영향은 제한적입니다.

Detailed Momentum

52-week position5.0Point

52w mid range (59%)

Current 15,450Won52-week high 18,11052-week low 11,500

1-month return3.0Point

1m 1.85% (flat)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0